ESC 365 - Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

ESC Premium Access

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

Session: Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Topic: Pathophysiology and Mechanisms

Speaker: Doctor P. Buettner (Leipzig, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Petra Buettner

Heart Center of Leipzig, Leipzig (Germany)

0 follower

9 more presentations in this session

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Speaker: Doctor E. Mironova (Moscow, RU)

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Speaker: Doctor T. Tu (Changsha, CN)

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Speaker: Professor G. Tse (Hong Kong, CN)

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Speaker: Doctor N. Kazem (Vienna, AT)

Ser96Ala genetic variant of human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation

Speaker: Doctor M. Amioka (Hiroshima, JP)

Access the full session

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Speakers: Doctor P. Buettner, Doctor E. Mironova, Doctor T. Tu, Professor G. Tse, Doctor N. Kazem...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources